NCT06218030View on ClinicalTrials.gov

Adjunctive Treatment With L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Pilot Study

PHASE4RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

April 1, 2026

Study Completion Date

May 1, 2026

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

L-methylfolate

Oral administration of L-methylfolate 15 mg per day for 8 weeks. The study drug will be given in addition to the standard of care (SOC) for GAD.

Trial Locations (1)

K7L 2V7

RECRUITING

Kingston Health Sciences Centre, Kingston

All Listed Sponsors
lead

Queen's University

OTHER